W.J. Hoogenraad

3.8k citations

23 papers · 2.8k indexed · 2 hit papers · h-index 17

Cancer Research top 0.5%
- Breast Cancer Treatment Studies 17
Radiation top 0.5%
- Advanced Radiotherapy Techniques 3
Pathology and Forensic Medicine top 1%
- Breast Lesions and Carcinomas 10
Oncology top 5%
- Cancer Risks and Factors 2
- Global Cancer Incidence and Screening 2
Otorhinolaryngology top 5%
Surgery
- Breast Implant and Reconstruction 4
Radiology, Nuclear Medicine and Imaging
- Advances in Oncology and Radiotherapy 3
Epidemiology
- Neuroendocrine Tumor Research Advances 2

Co-authors: Alain Fourquet Harry Bartelink Laurence Collette M. Piérart J.J. Jager H. Struikmans Philip Poortmans Jean-Claude Horiot
Cited by: Cancer Research Radiation Pathology and Forensic Medicine
Journals: New England Journal of Medicine (1 paper)Journal of Clinical Oncology (1 paper)Cancer (1 paper)
Partner nations: Netherlands France Belgium

In The Last Decade

W.J. Hoogenraad

22 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by W.J. Hoogenraad

Since Specialization

Citations

This map shows the geographic impact of W.J. Hoogenraad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.J. Hoogenraad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.J. Hoogenraad more than expected).

Fields of papers citing papers by W.J. Hoogenraad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.J. Hoogenraad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.J. Hoogenraad. The network helps show where W.J. Hoogenraad may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W.J. Hoogenraad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W.J. Hoogenraad Line = papers co-authored together W.J. Hoogenraad links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’ European Journal of Cancer ·Sandra Collette,Laurence Collette,Tom Budiharto,Jean-Claude Horiot,Philip Poortmans,H. Struikmans,Walter Van den Bogaert,Alain Fourquet,J.J. Jager,W.J. Hoogenraad,Rolf‐Peter Mueller,John M. Kurtz,D.A.L. Morgan,Jean‐Bernard Dubois,E. Salamon,R.O. Mirimanoff,M. Bolla,Marleen van der Hulst,Carla C. Wárlám-Rodenhuis,Harry Bartelink	2008	157
2	Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial Radiotherapy and Oncology ·Philip Poortmans,Laurence Collette,Jean-Claude Horiot,Walter F. Van den Bogaert,Alain Fourquet,Abraham Kuten,Evert M. Noordijk,W.J. Hoogenraad,René‐Olivier Mirimanoff,M. Piérart,Erik Van Limbergen,Harry Bartelink	2008	107
3	The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 “boost versus no boost” trial Cancer/Radiothérapie ·Philip Poortmans,Laurence Collette,Harry Bartelink,H. Struikmans,Walter F. Van den Bogaert,Alain Fourquet,J.J. Jager,W.J. Hoogenraad,R.-P. Müller,J.-B. Dubois,M. Bolla,M. van der Hulst,Carla C. Wárlám-Rodenhuis,M. Piérart,J.-C. Horiot	2008	76
4	The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial European Journal of Cancer Supplements ·Helen Jones,Ninja Antonini,Laurence Collette,Alain Fourquet,W.J. Hoogenraad,J.J. Jager,Hans Peterse,P. Poortmans,H. Struikmans,Harry Bartelink	2008	0
5	The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial International Journal of Radiation OncologyBiologyPhysics ·Helen Jones,Ninja Antonini,L. Colette,Alain Fourquet,W.J. Hoogenraad,W. Van den Bogaert,J.J. Jager,P. Poortmans,H. Struikmans,Harry Bartelink	2007	6
6	Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trialbreakdown → Journal of Clinical Oncology ·Harry Bartelink,Jean-Claude Horiot,Philip Poortmans,H. Struikmans,Walter Van den Bogaert,Alain Fourquet,J.J. Jager,W.J. Hoogenraad,S.B. Oei,Carla C. Wárlám-Rodenhuis,M. Piérart,Laurence Collette	2007	722
7	Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882 Radiotherapy and Oncology ·Ninja Antonini,Heather Jones,Jean Claude Horiot,Philip Poortmans,H. Struikmans,Walter Van den Bogaert,I. Barillot,Alain Fourquet,J.J. Jager,W.J. Hoogenraad,Laurence Collette,M. Piérart,Guus Hart,Harry Bartelink	2006	120
8	The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial Radiotherapy and Oncology ·Philip Poortmans,Harry Bartelink,Jean-Claude Horiot,H. Struikmans,Walter Van den Bogaert,Alain Fourquet,J.J. Jager,W.J. Hoogenraad,Patrick Rodrigus,Carla C. Wárlám-Rodenhuis,Laurence Collette,M. Piérart	2004	114
9	The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial European Journal of Cancer Supplements ·P. Poortmans,H. Bartelink,J.C. Horiot,H. Struikmans,W. Van den Bogaert,Alain Fourquet,J.J. Jager,W.J. Hoogenraad,Patrick Rodrigus,Carla C. Wárlám-Rodenhuis,Laurence Collette,M. Piérart	2004	18
10	Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? European Journal of Cancer ·Conny Vrieling,Laurence Collette,Alain Fourquet,W.J. Hoogenraad,Jean-Claude Horiot,J.J. Jager,S.B. Oei,Hans Peterse,M. Piérart,P. Poortmans,H. Struikmans,W. Van den Bogaert,Harry Bartelink	2003	130
11	Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·H. Bartelink,P Poortmans,H. Struikmans,Jacques Borger,Josephus J. de Jager,W.J. Hoogenraad,W. Van den Bogaert,I. Barillot,Alain Fourquet,Laurence Collette,M. Piérart,J.C. Horiot	2002	1
12	Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiationbreakdown → New England Journal of Medicine ·Harry Bartelink,Jean-Claude Horiot,Philip Poortmans,H. Struikmans,Walter Van den Bogaert,I. Barillot,Alain Fourquet,Jacques Borger,J.J. Jager,W.J. Hoogenraad,Laurence Collette,M. Piérart	2001	693
13	The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial Radiotherapy and Oncology ·Conny Vrieling,Laurence Collette,Alain Fourquet,W.J. Hoogenraad,J.C. Horiot,J.J. Jager,M. Piérart,Philip Poortmans,H. Struikmans,B. Maat,Erik Van Limbergen,Harry Bartelink	2000	250
14	The influence of the boost in breast-conserving therapy on cosmetic outcome in the eortc “boost versus no boost” trial International Journal of Radiation OncologyBiologyPhysics ·Conny Vrieling,Laurence Collette,Alain Fourquet,W.J. Hoogenraad,Jean-Claude Horiot,J.J. Jager,M. Piérart,Philip Poortmans,H. Struikmans,Marleen van der Hulst,Emmanuel van der Schueren,Harry Bartelink	1999	128
15	Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: An EORTC GITCCG study European Journal of Cancer ·D.J.Th. Wagener,W.J. Hoogenraad,Ph. Rougier,A. Lusinchi,Babs G. Taal,C.H.N. Veenhof,Alexander de Graeff,Thierry Conroy,Desmond Curran,Tarek Sahmoud,J. Wils	1996	16
16	Patient population analysis in eortc trial 22881/10882 on the role of a booster dose in breast-conserving therapy European Journal of Cancer ·A. Ptaszynski,W. Van den Bogaert,M. van Glabbeke,M. Piérart,Harry Bartelink,Jean-Claude Horiot,Alain Fourquet,H. Struikmans,Han Hamers,R.-P. Müller,W.J. Hoogenraad,J.J. Jager,Emmanuel van der Schueren	1994	22
17	Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity International Journal of Radiation OncologyBiologyPhysics ·Johannes H.A.M. Kaanders,W.A.J. van Daal,W.J. Hoogenraad,Albert J. van der Kogel	1992	50
18	Local control in t3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model International Journal of Radiation OncologyBiologyPhysics ·C. Terhaard,A.B.M.F. Karim,W.J. Hoogenraad,R.E. Tjho‐Heslinga,Ronald B. Keus,D. M. Mehta,B. Reichgelt,G.J. Hordijk	1991	23
19	Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in the Netherlands Cancer ·A. D. Treurniet-Donker,Wim L.J. van Putten,J. C. J. Wereldsma,E. D. M. Bruggink,W.J. Hoogenraad,Jan A. Roukema,A. Snijders-Keilholz,Willem S. Meijer,J.H. Meerwaldt,Arendjan Wijnmaalen,Th. Wiggers	1991	103
20	Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer Cancer Chemotherapy and Pharmacology ·D. J. Th. Wagener,Q.G.C.M. van Hoesel,Sing Hiem Yap,W.J. Hoogenraad,Th. Wobbes,S P Strijk	1989	16

About W.J. Hoogenraad

W.J. Hoogenraad is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 23 papers that have together received 2.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (10 papers), Breast Implant and Reconstruction (4 papers), Advanced Radiotherapy Techniques (3 papers), Advances in Oncology and Radiotherapy (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Risks and Factors (2 papers) and Global Cancer Incidence and Screening (2 papers). The work is most often cited by research in Cancer Research (2.2k citations), Radiation (868 citations) and Pathology and Forensic Medicine (1.2k citations). W.J. Hoogenraad has collaborated with scholars based in Netherlands, France and Belgium. Frequent co-authors include Alain Fourquet, Harry Bartelink, Laurence Collette, M. Piérart, J.J. Jager, H. Struikmans, Philip Poortmans, Jean-Claude Horiot, Walter Van den Bogaert and Carla C. Wárlám-Rodenhuis. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact